Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Preoperative white blood cell count predicts anastomotic leakage in patients with left-sided colorectal cancer

  • Masaki Morimoto ,

    Roles Conceptualization, Validation, Writing – original draft

    2s.morimoto@gmail.com

    Affiliations National Hospital Organization, Yonago Medical Center, Yonago, Japan, Faculty of Medicine, Division of Gastrointestinal Surgery, Department of Surgery, Tottori University, Yonago, Japan

  • Kenjiro Taniguchi,

    Roles Data curation, Investigation

    Affiliation National Hospital Organization, Yonago Medical Center, Yonago, Japan

  • Osamu Yamamoto,

    Roles Data curation, Investigation

    Affiliation National Hospital Organization, Yonago Medical Center, Yonago, Japan

  • Takuji Naka,

    Roles Data curation, Investigation

    Affiliation National Hospital Organization, Yonago Medical Center, Yonago, Japan

  • Atsushi Sugitani,

    Roles Data curation, Investigation

    Affiliation National Hospital Organization, Yonago Medical Center, Yonago, Japan

  • Yoshiyuki Fujiwara

    Roles Project administration, Writing – review & editing

    Affiliation Faculty of Medicine, Division of Gastrointestinal Surgery, Department of Surgery, Tottori University, Yonago, Japan

Abstract

To determine whether preoperative white blood cell (WBC) counts reflect risk of anastomotic leak (AL) for patients with colorectal cancer (CRC), we retrospectively examined data from records of 208 consecutive patients who had undergone resections for left-sided CRC, including their clinicopathological parameters and preoperative laboratory data. The diagnostic value of WBC count for AL was evaluated and compared with those of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, lymphocyte-monocyte ratio and platelet count × C-reactive protein level multiplier (P-CRP) value; optimal cut-off values were derived from receiver operating characteristic curves. AL was observed in 11 of the 208 patients (5.3%). Compared with the no-AL group, the AL group had a significantly higher mean WBC count and smoking rate. In multivariate analysis, WBC count and smoking were independent risk factors for AL. Compared with the other tested inflammatory indicators, the cut-off value for WBC (6,200/μL) had the highest sensitivity (81.8%) and negative predictive value (98.4%), as well as the lowest likelihood ratio (0.289). Preoperative WBC count could therefore be a convenient predictor of AL in patients with left-sided CRC.

Introduction

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and the second-most common cancer in women [1]. A serious complication of surgery for CRC is anastomotic leakage (AL), a major cause of postoperative mortality and morbidity. Its incidence is reportedly 3%–30% [2,3]. AL not only causes mortality itself, but also delays adjuvant chemotherapy, thus increasing the risk of recurrence and fatal outcome. AL also increases the length and cost of hospitalization. For these reasons, AL prevention is a major consideration in colorectal surgery for patients with CRC.

Although some preoperative risk factors of AL for colorectal surgery have been suggested, no consensus has yet formed. No reliable detailed data about the relationship between AL and preoperative inflammation is available, especially for patients with left-sided CRC. In this study, we focused on the potential of preoperative inflammation-related indicators as risk factors for AL after surgeries for left-sided CRC.

Materials and methods

Patients

This retrospective study included 208 consecutive patients with left-sided (descending colon, sigmoid colon, rectum and anal canal) CRC who underwent elective colorectal resection and anastomosis at the National Hospital Organization, Yonago Medical Center (Yonago, Japan) between August 2014 and August 2020, either by open laparotomy or laparoscopic surgery. The location of left-sided CRC was determined by the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma [4]. CRC patients were classified by clinical symptoms and pathological detection by the 8th edition of the Union for International Cancer Control TNM staging system.

Preoperative antibiotics were not used routinely and mechanical preparation of the colon was conducted by the individual physicians, typically using laxatives for 1–2 day(s) before operation. All patients received postoperative antibiotic prophylaxis. Prophylactic antibiotics (e.g., flomoxef) were administered within 30 min before skin incision, and then every 3 h intraoperatively. Prophylactic postoperative antibiotics were typically used until POD 1, and were the same antibiotics as those used intraoperatively.

The ethical review board of the National Hospital Organization, Yonago Medical Center, approved of the study (approval No. 0211–02) and the informed consent requirement was waived.

Parameters

Patients’ clinicopathological and laboratory data were extracted from their electronic medical records, and included characteristics such as age, sex, body mass index (BMI), smoking, diabetes, neoadjuvant chemotherapy (NAC), tumor location, T/N stage, preoperative laboratory data, and surgical parameters such as operative approach, diverting stoma, anastomotic method, procedure duration and blood loss volume.

Data on preoperative serum C-reactive protein (CRP), white blood cell (WBC) count, cell counts for neutrophils, lymphocytes, monocytes, eosinophils, and platelets, and serum albumin levels, were collected within 1 month before their surgeries.

Diagnosis of AL

AL was diagnosed through clinical and radiologic findings: (a) presence of air or abscess near the site of anastomosis detected on computed tomography (CT); (b) purulent or enteric discharge through the drainage tube; and/or (c) clinical signs of peritonitis and/or presence of fecal or purulent discharge during re-operation.

Statistical analysis

Continuous variables are reported as means and standard deviations. Univariate analyses were performed using Fisher’s exact test for categorical variables and the Mann–Whitney U-test for continuous variables. Logistic regression analysis was used to calculate odds ratios (ORs) for multivariate analysis. Receiver operating characteristic (ROC) analyses were used to evaluate predictors for AL and to determine cut-off values. The cut off value was determined according to the point on the curve with minimum distance from the left-upper corner of the unit square, in order to compare the predicting properties between inflammatory factors. All statistical analyses were performed using the statistical software SPSS v. 23.0 statistical software (IBM Corporation, Armonk, New York, USA). P < 0.05 was considered significant.

Results

In the period of this study, 208 patients underwent colorectal resection for left-sided CRC; all these patients were included in this analysis. Their median age was 69 (±11.1) years; 112 patients (53.9%) were men. Sigmoid colon cancer (n = 100, 48.1%) was the most common surgical indication, followed by rectosigmoid (n = 59, 28.4%), descending (n = 19, 9.1%), upper rectum (n = 18, 8.7%), lower rectum (n = 11, 5.3%) and anal canal (n = 1, 0.5%). The operative approaches were laparoscopic (n = 125, 60.1%) and open laparotomy (n = 83, 39.9%). Anastomoses were performed using a mechanical stapler in 122 patients (58.7%) and hand sutures in 86 patients (41.4%).

AL was observed in 11 of 208 (5.3%) patients; this cohort was defined as the AL group. Their AL was diagnosed between post-operative days (PODs) 1 and 13 (median: POD 4). To treat AL, 7 patients received ileostomies (64%), 3 received conventional drainage tubes (27%), and 1 underwent Hartmann’s operation (9%). The AL group suffered no AL-related deaths. The remaining 197 patients were classified as the no-AL group. Table 1 summarizes patient characteristics for the two groups. Mean age, sex, BMI, diabetes, neoadjuvant chemotherapy, pathological T and N statuses, tumor location, operative approaches, diverting stoma, anastomotic method, operation time, blood loss volume, preoperative CRP, preoperative proportions of neutrophils, lymphocytes, monocytes and eosinophils, preoperative platelets and preoperative albumin did not significantly differ between the AL and no-AL groups. However, the AL group had a significantly higher mean WBC (7000±2200/μL vs 5600±1700 /μL, P = 0.0023) and smoking rate (63.6% vs 18.3%, P = 0.0018).

thumbnail
Table 1. Associations between AL and clinicopathological factors.

https://doi.org/10.1371/journal.pone.0258713.t001

In multivariate analysis, WBC count (OR: 1.51, P = 0.00059) and smoking (OR: 6.14, P = 0.00077) were independent risk factors for AL (Table 2).

thumbnail
Table 2. Multivariate analysis of prognostic factors for AL.

https://doi.org/10.1371/journal.pone.0258713.t002

In consideration of the role that preoperative inflammatory indicators, such WBC count, play in diagnosing AL, we then examined WBC and other inflammatory indexes, including neutrophil-lymphocyte ratio (NLR) [5], platelet-lymphocyte ratio (PLR) [6], lymphocyte-monocyte ratio (LMR) [7] and platelet count × C-reactive protein level multiplier (P-CRP) value [8] with respect to AL, using ROC analyses. The cut-off values were WBC: 6,200/μL (area under the curve [AUC] = 0.773), NLR: 2.7 (AUC = 0.53), PLR: 153.6, (AUC = 0.503), LMR: 3.4 (AUC = 0.606) and P-CRP: 8.3 (AUC = 0.653; Table 3; Fig 1).

thumbnail
Fig 1. Receiver operating characteristic (ROC) curves and areas under the curve (AUC) of the possible predictors of anastomotic leakage.

White blood cell; WBC, Neutrophil-lymphocyte ratio; NLR, Platelet-lymphocyte ratio; PLR, Lymphocyte-monocyte ratio; LMR, Platelet count × C-reactive protein level multiplier; P-CRP.

https://doi.org/10.1371/journal.pone.0258713.g001

thumbnail
Table 3. AUC and cut-off values for clinical predictors of AL.

https://doi.org/10.1371/journal.pone.0258713.t003

Finally, we used the cut-off values to determine the effectiveness of these indicators for AL. We found that WBC count was the most accurate, at 81.8% sensitivity, 98.4% negative predictive value, and 0.289 of negative likelihood ratio for predicting AL in our study cohort (Table 4).

thumbnail
Table 4. Diagnostic properties for clinical predictors of AL.

https://doi.org/10.1371/journal.pone.0258713.t004

Discussion

Patients with AL can experience fever, abscess, septicemia, metabolic disturbances, or multiple organ failure [9], which could lead to the need for reoperation, higher risk of local recurrence, increased morbidity and mortality and diminished general quality of life [10,11]. Therefore, various surgical techniques and prevention methods have been developed to overcome AL [12]. For example, recent prospective and retrospective studies show that the use of a trans- anal drainage tube significantly reduces AL [13,14] by lowering endo-luminal pressure at the anastomotic line.

To prevent the worst outcomes in patients with AL, early diagnosis, from indications and symptoms such as fever and peritonitis, is crucial. In recent years, CT, abdominal drain secretion analysis and biomarkers are the most commonly used strategies to diagnose AL [1517].

If the patient’s ability to naturally heal is compromised, AL can occur, even if the surgery is without fault. Therefore, the ability to predict which patients are at high risk for AL would facilitate more careful monitoring and faster diagnosis for AL among these patients. Smoking [18], obesity [19] and male sex [20] are reported to be preoperative risk factors for AL. However, the current study found no significant differences in AL rates related to BMI and sex.

Thus, consensus on the role of preoperative factors for predicting AL risk in patients with CRC is lacking. Our study therefore focused on this unsolved issue, with a particular focus on inflammatory indicators’ predictive value for AL, using well-recorded preoperative data for our cohort.

The relationship between cancer and inflammation has been known ever since Rudolf Virchow first reported the presence of leukocytes within tumors in the 19th century [21]; the underlying molecular mechanisms are still obscure [22]. The contribution of inflammation and the immune system to cancer progression has driven a great deal of research. Several indicators based on common inflammatory factors, such as CRP, platelets and WBC, have prognostic value in various cancers [6,23,24]. These indicators have the advantages of simplicity and convenience, but the mechanisms by which they affect tumorigenesis are unclear. Nonetheless, a common mechanism underlying their prognostic value is an association with systemic and/or local inflammation.

Messias et al. reported that postoperative serum CRP levels in patients who undergo colorectal surgery could become a marker for the exclusion of anastomotic leakage [25]. Additionally, Smith et al. reported changes in CRP, WBC count and procalcitonin as potential markers of AL following colorectal surgery [26]. Those reports indicate that the postoperative trend of inflammatory indicators reflects the occurrence of AL. Actually, in this study, CRP and WBC at POD 3 were significantly higher in the AL group compared with the no-AL group (data not shown).

However, preoperative predictors for AL have not been widely studied. Although patients with cancer often have some inflammation that reflect their cancer progression, whether preoperative inflammatory status reflects AL risk in patients with CRC has not been examined.

To address this issue, this study analyzed preoperative predictors of AL in 208 patients who underwent resections for left-sided CRC. First, univariate analyses showed that the patients with AL had a significantly higher mean WBC count than did those without AL. Second, multivariate analysis showed that WBC count was independently related to AL risk. Third, ROC analyses showed that WBC count had the highest AUC (0.773), compared with NLR, PLR, LMR and P-CRP. Finally, high WBC count had the highest sensitivity and negative predictive value, and the lowest likelihood ratio, using the cut-off value (6,200/ μL). Preoperative WBC levels in patients with left-sided CRC can become a useful marker to rule out AL.

These results reflect the influence of tumor-related inflammation in patients with CRC on the healing process of the intestinal anastomosis created in their resections.

Generally, excessive inflammation is a key contributor to wound pathology, which lengthens recovery through the continued destruction of wound tissue. Along with elevated infiltration by specific immune cell subsets, pathological immune cell function is perturbed and collectively contributes to poor healing [27].

Buck et al. suggested that tumor necrosis factor-α, which is a proinflammatory cytokine predominantly produced by macrophages and tumor cells [28], can be a humoral mediator of impaired wound healing in patients with chronic diseases, including cancer associated with cachexia [29]. Additionally, tumors reportedly delayed wound closure in a murine animal model [30].

Taken together, tumors can potentially inhibit wound healing, even after being resected. Preoperative tumor-associated inflammation not only affects oncogenicity, but also reflect the patient’s ability to heal, including in intestinal anastomotic sites. However, the mechanisms and clinical effects are still unclear and should be studied in detail.

This study has some limitations. It is a single-institution, retrospective study. Nevertheless, as very few studies have focused on the relationships of preoperative inflammatory indicators and the occurrence of AL in left-sided CRC, the results presented here may help stratify patients who undergo surgery into high- and low-risk for AL.

To summarize, this study revealed that preoperative WBC count may help predict postoperative AL risk in left-sided CRC. It can make it possible to identify the risk of AL preoperatively and to take preventive methods efficiently. However, the predictive role of inflammatory indicators should be verified in larger-scale clinical studies. In particular, to use AL preventing methods more efficiently, it should be approached by interventional prospective studies with the preventing methods, stratified by preoperative WBC count.

Acknowledgments

The authors would like to thank the nurses, doctors, and other staff responsible for the patients’ care at Yonago Medical Center. We also thank Marla Brunker, from Edanz (https://en-author-services.edanz.com/ac) for editing a draft of this manuscript.

References

  1. 1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65: 87–108. pmid:25651787
  2. 2. Nikolian VC, Kamdar NS, Regenbogen SE, Morris AM, Byrn JC, Suwanabol PA, et al. Anastomotic leak after colorectal resection: A population-based study of risk factors and hospital variation. Surgery. 2017;161: 1619–1627. pmid:28238345
  3. 3. Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg. 2009;208: 269–278. pmid:19228539
  4. 4. Japanese Society for Cancer of the Colon and Rectum. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication]. J Anus Rectum Colon. 2019;3: 175–195. pmid:31768468
  5. 5. Guthrie GJK, Charles KA, Roxburgh CSD, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88: 218–230. pmid:23602134
  6. 6. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI. Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200: 197–203. pmid:20122680
  7. 7. Chan JCY, Chan DL, Diakos CI, Engel A, Pavlakis N, Gill A, et al. The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2017;265: 539–546. pmid:27070934
  8. 8. Morimoto M, Honjo S, Sakamoto T, Yagyu T, Uchinaka E, Hanaki T, et al. Prognostic Impact of Pre- and Post-operative P-CRP Levels in Pancreatic Cancer Patients. Yonago Acta Med. 2020;63: 70–78. pmid:32158336
  9. 9. Campbell WB. Proposed definitions for the audit of postoperative infection: a discussion paper. Annals of the Royal College of Surgeons of England. 1992. p. 151.
  10. 10. Mirnezami A, Mirnezami R, Chandrakumaran K, Sasapu K, Sagar P, Finan P. Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak: systematic review and meta-analysis. Ann Surg. 2011;253: 890–899. pmid:21394013
  11. 11. Jannasch O, Klinge T, Otto R, Chiapponi C, Udelnow A, Lippert H, et al. Risk factors, short and long term outcome of anastomotic leaks in rectal cancer. Oncotarget. 2015;6: 36884–36893. pmid:26392333
  12. 12. Fang AH, Chao W, Ecker M. Review of Colonic Anastomotic Leakage and Prevention Methods. J Clin Med Res. 2020;9. pmid:33339209
  13. 13. Nishigori H, Ito M, Nishizawa Y, Nishizawa Y, Kobayashi A, Sugito M, et al. Effectiveness of a transanal tube for the prevention of anastomotic leakage after rectal cancer surgery. World J Surg. 2014 Jul;38(7):1843–51. pmid:24378550
  14. 14. Tanaka K, Okuda J, Yamamoto S, Ito M, Sakamoto K, Kokuba Y, et al. Risk factors for anastomotic leakage after laparoscopic surgery with the double stapling technique for stage 0/I rectal carcinoma: a subgroup analysis of a multicenter, single-arm phase II trial. Surg Today. 2017 Oct;47(10):1215–22. pmid:28280982
  15. 15. Vallance A, Wexner S, Berho M, Cahill R, Coleman M, Haboubi N, et al. A collaborative review of the current concepts and challenges of anastomotic leaks in colorectal surgery. Colorectal Dis. 2017;19: O1–O12. pmid:27671222
  16. 16. Gessler B, Eriksson O, Angenete E. Diagnosis, treatment, and consequences of anastomotic leakage in colorectal surgery. Int J Colorectal Dis. 2017;32: 549–556. pmid:28070659
  17. 17. McSorley ST, Khor BY, MacKay GJ, Horgan PG, McMillan DC. Examination of a CRP first approach for the detection of postoperative complications in patients undergoing surgery for colorectal cancer: A pragmatic study. Medicine. 2017;96: e6133. pmid:28207541
  18. 18. Sørensen LT, Jørgensen T, Kirkeby LT, Skovdal J, Vennits B, Wille-Jørgensen P. Smoking and alcohol abuse are major risk factors for anastomotic leakage in colorectal surgery. Br J Surg. 1999;86: 927–931. pmid:10417567
  19. 19. Volk A, Kersting S, Held HC, Saeger HD. Risk factors for morbidity and mortality after single-layer continuous suture for ileocolonic anastomosis. Int J Colorectal Dis. 2011;26: 321–327. pmid:20697722
  20. 20. Kartheuser AH, Leonard DF, Penninckx F, Paterson HM, Brandt D, Remue C, et al. Waist circumference and waist/hip ratio are better predictive risk factors for mortality and morbidity after colorectal surgery than body mass index and body surface area. Ann Surg. 2013;258: 722–730. pmid:24096768
  21. 21. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357: 539–545. pmid:11229684
  22. 22. Chang L, Kamata H, Solinas G, Luo J-L, Maeda S, Venuprasad K, et al. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell. 2006;124: 601–613. pmid:16469705
  23. 23. Rossi S, Basso M, Strippoli A, Schinzari G, D’Argento E, Larocca M, et al. Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? Clin Colorectal Cancer. 2017;16: 264–274. pmid:28412137
  24. 24. Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89: 1028–1030. pmid:12966420
  25. 25. Messias BA, Botelho RV, Saad SS, Mocchetti ER, Turke KC, Waisberg J. Serum C-reactive protein is a useful marker to exclude anastomotic leakage after colorectal surgery. Sci Rep. 2020;10: 1687. pmid:32015374
  26. 26. Smith SR, Pockney P, Holmes R, Doig F, Attia J, Holliday E, et al. Biomarkers and anastomotic leakage in colorectal surgery: C-reactive protein trajectory is the gold standard. ANZ J Surg. 2018;88: 440–444. pmid:28304142
  27. 27. Wilkinson HN, Hardman MJ. Wound healing: cellular mechanisms and pathological outcomes. Open Biol. 2020;10: 200223. pmid:32993416
  28. 28. Zins K, Abraham D, Sioud M, Aharinejad S. Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway. Cancer Res. 2007;67: 1038–1045. pmid:17283136
  29. 29. Buck M, Houglum K, Chojkier M. Tumor necrosis factor-alpha inhibits collagen alpha1(I) gene expression and wound healing in a murine model of cachexia. Am J Pathol. 1996;149: 195–204. pmid:8686743
  30. 30. Pyter LM, Husain Y, Calero H, McKim DB, Lin H-Y, Godbout JP, et al. Tumors Alter Inflammation and Impair Dermal Wound Healing in Female Mice. PLoS One. 2016;11: e0161537. pmid:27548621